Cargando…
The immunomodulatory role of IDO1-Kynurenine-NAD(+) pathway in switching cold tumor microenvironment in PDAC
Pancreatic ductal adenocarcinoma (PDAC) is the most common exocrine tumor of the pancreas characterized by late diagnosis, adverse overall 5-year survival, a higher propensity for metastatic disease, and lack of efficacy of systemic therapy options. These adverse outcomes can be partly attributed to...
Autores principales: | Anu, R. I., Shiu, Kai-Keen, Khan, Khurum Hayat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10348419/ https://www.ncbi.nlm.nih.gov/pubmed/37456260 http://dx.doi.org/10.3389/fonc.2023.1142838 |
Ejemplares similares
-
IDO/kynurenine pathway in cancer: possible therapeutic approaches
por: Abd El-Fattah, Eslam E.
Publicado: (2022) -
IDO and Kynurenine Metabolites in Peripheral and CNS Disorders
por: Huang, Yi-Shu, et al.
Publicado: (2020) -
Interactions of IDO and the Kynurenine Pathway with Cell Transduction Systems and Metabolism at the Inflammation–Cancer Interface
por: Stone, Trevor W., et al.
Publicado: (2023) -
Immunomodulatory Effects of Genetic Alterations Affecting the Kynurenine Pathway
por: Boros, Fanni A., et al.
Publicado: (2019) -
Hypoxic preconditioning protects against ischemic kidney injury through the IDO1/kynurenine pathway
por: Torosyan, Rafael, et al.
Publicado: (2021)